CAS 98063-21-9
:(3R)-3-amino-4-(triméthylammonio)butanoate
(R)-Amino carnitine
CAS :Degré de pureté :≥ 97.0%Couleur et forme :Off-white to yellow or tan solidMasse moléculaire :160.21(R)-Aminocarnitine
CAS :(R)-AminocarnitineFormule :C7H16N2O3Degré de pureté :≥95%Couleur et forme : pale yellow solidMasse moléculaire :176.21g/mol(R)-Amino Carnitine
CAS :Produit contrôléStability Hygroscopic
Applications An inhibitor of fatty acid oxidation. Aminocarnitine acts as a hypoglycemic and antiketogenic compound. It alters lipidic metabolism by inhibiting carnitine acetyltransferase (CAT) and carnitine palmitoyltransferase (CPT).
References Jenkins, D.L., et al.: J. Biol. Chem., 260, 14748 (1985), Kanamaru, T., et al.: M. Life Sci., 37, 217 (1985), Hulsmann, W.C., et al.: J. Biochim. Biophys. Acta., 1097, 263 (1991), Chiodi, P., et al.: Biochim, Biophys. Acta., 1127, 81 (1992),Formule :C7H16N2O2Couleur et forme :Off-White To BrownMasse moléculaire :160.21(R)-Amino carnitine
CAS :(R)-Amino carnitine is a pancreatic enzyme that is used as an experimental treatment for fatty liver disease. It has been shown to inhibit the synthesis of fatty acids, which are the main components of triglycerides. The inhibition of this enzyme leads to a decrease in the production of triglycerides and their accumulation in the liver, thereby reducing hepatic steatosis. (R)-Amino carnitine also has an inhibitory effect on protein synthesis, which is important for the conversion of amino acids into proteins essential for cell division and growth. This mechanism may explain its beneficial effects on insulin resistance, obesity, and diabetes.
Formule :C7H16N2O2Degré de pureté :Min. 95%Masse moléculaire :160.21 g/molAminocarnitine
CAS :Aminocarnitine inhibits fat oxidation, has hypoglycemic and antiketogenic effects, and blocks CAT and CPT enzymes.Formule :C7H16N2O2Couleur et forme :SolidMasse moléculaire :160.21




